• Title/Summary/Keyword: CNKI

Search Result 529, Processing Time 0.027 seconds

Cyclooxygenase-2 Promoter 765C Increase of Digestive Tract Cancer Risk in the Chinese Population: a Meta-analysis

  • Xu, Yan-Song;Zhao, Bo;Long, Chen-Yan;Li, Hui;Lu, Xing;Liu, Gang;Tang, Xiao-Zhun;Tang, Wei-Zhong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.11
    • /
    • pp.4563-4566
    • /
    • 2014
  • Background: To evaluate relationship between the cyclooxygenase-2 promoter 765G/C polymorphism and digestive cancer risk in China. Materials and Methods: A literature search through February 2014 was performed using PubMed, Chinese Biomedical Literature Database (CBM) and China National Knowledge Infrastructure (CNKI) databases, and a meta-analysis was performed with RevMan 5.2 software for odds ratios and 95%CIs. Results: In total, 9 articles with 3,263 cases and 4,858 controls were included in this meta-analysis. The pooled OR (95%CIs) in the co-dominant model (GC vs GG) was 1.56 [1.19, 2.06], and in the dominant model ((CC+GC) vs GG), the pooled OR was 1.59 [1.21, 2.09] in overall cancers. In the subgroup analysis, stratified by cancer type, significant associations were found that the-765C allele had increased pancreatic cancer and gastric risk. No significant liver cancer and colorectal cancer risk of COX-2 -765G/C polymorphism was found. Conclusions: These findings suggest that COX-2-765*C is related to cancer susceptibility and may increase gastric and pancreatic cancer risk.

Associations Between RASSF1A Promoter Methylation and NSCLC: A Meta-analysis of Published Data

  • Liu, Wen-Jian;Tan, Xiao-Hong;Guo, Bao-Ping;Ke, Qing;Sun, Jie;Cen, Hong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.6
    • /
    • pp.3719-3724
    • /
    • 2013
  • Background: RASSF1A has been reported to be a candidate tumor suppressor in non-small cell lung cancer (NSCLC). However, the association between RASSF1A promoter methylation and NSCLC remains unclear, particularly in regarding links to clinicopathologic features. Methods: Eligible studies were identified through searching PubMed, EMBASE, Cochrane Library and China National Knowledge Infrastructure (CNKI) databases. Studies were pooled and odds ratios (ORs) with corresponding confidence intervals (CIs) were calculated. Funnel plots were also performed to evaluate publication bias. Results: Nineteen studies involving 2,063 cases of NSCLC and 1,184 controls were included in this meta-analysis. A significant association was observed between RASSF1A methylation and NSCLC in the complete data set (OR = 19.42, 95% CI: 14.04-26.85, P < 0.001). Pooling the control tissue subgroups (heterogeneous/autologous) gave pooled ORs of 32.4 (95% CI, 12.4-84.5) and 17.7 (95% CI, 12.5-25.0) respectively. Racial subgroup (Caucasian/Asian) analysis gave pooled ORs of 26.6 (95% CI, 10.9-64.9) and 20.9 (95% CI, 14.4-30.4) respectively. The OR for RASSF1A methylation in poorly-differentiated vs. moderately/well-differentiated NSCLC tissues was 1.88 (95% CI, 1.32-2.68, P<0.001), whereas there were no significant differences in RASSF1A methylation in relation to gender, pathology, TNM stage and smoking behavior among NSCLC cases. Conclusion: This meta-analysis suggests a significant association between RASSF1A methylation and NSCLC, confirming the role of RASSF1A as a tumor suppressor gene. Large-scale and well-designed case-control studies are needed to validate the associations identified in the present meta-analysis.

Review of Clinical Studies of Herbal Medicine Treatment for Pediatric Epistaxis - Focused on Chinese Randomized Controlled Trials after 2000s - (소아 비출혈의 한약 치료에 대한 임상 연구 동향 - 2000년대 이후 발표된 중국 RCT 연구를 중심으로 -)

  • Park, Yong Seok;Shin, Hye Jin;Lee, Jihong;Chang, Gyu Tae
    • The Journal of Pediatrics of Korean Medicine
    • /
    • v.34 no.1
    • /
    • pp.48-60
    • /
    • 2020
  • Objectives The purpose of this study is to investigate recent clinical studies on the effect of herbal medicine for pediatric epistaxis in China, and to seek better methods to treat and study for pediatric epistaxis in Republic of Korea. Methods We searched the clinical studies from the China Academic Journal (CAJ) in China National Knowledge Infrastructure (CNKI) by key words 鼻出血', '鼻衄', '衄血', '中藥', '中医藥', '本草', '湯', '丸', '散', '方','顆粒', '膠囊', '自擬', '外用', '膏 from January 2000 to November 2019. We analyzed the literature in regards to the treatment methods and results. Results Among the 1141 searched studies, 12 randomized controlled trials were selected and analyzed. In most of the studies, the effectiveness of herbal medicine on pediatric epistaxis was significantly high. The most commonly used herbs for oral administration were Rehmanniae Radix (生地黃), Scutellariae Radix (黃芩), Imperatae Rhizoma (白茅根). The most commonly used herbs for external applications were Notoginseng Radix (三七), Bletilla striata (白芨), Crinis Carbonisatus (血餘炭). Conclusions Herbal medicine treatment can help improve pediatric epistaxis. Additional studies need to be performed to solidify these findings. In addition to that, unified criteria for treatment of pediatric epistaxis should be established in Republic of Korea.

A Review on Treatment of Somatization Disorder in Traditional Chinese Medicine (신체화 장애에 대한 중의학 연구동향)

  • Kim, Hyo-seop;Bae, Jin-soo;Lee, Seung-Hwan;Lim, Jung-Hwa;Seong, Woo-Yong
    • Journal of Oriental Neuropsychiatry
    • /
    • v.28 no.3
    • /
    • pp.217-230
    • /
    • 2017
  • Objectives: This study was conducted to review studies on somatization disorder in traditional Chinese medicine. Methods: We reviewed studies in the China National Knowledge Infrastructure (CNKI) to 2017. Keywords were 軀體化障碍, Somatization disorder, somatic symptom disorder. We included Randomized Controlled Trial (RCT), and excluded non-Randomized Controlled Trial (nRCT), non-related somatization disorder or traditional Chinese medicine, non-clinical trials, dissertations for degrees. Jadad scale and Cochrane Library's Risk of Bias (RoB) were used for assessment of the quality of studies. Results: Twelve studies were selected. The Chinese Classification of Mental Disorders-3 (CCMD-3) was most frequently used as diagnostic criteria for somatization disorder. As for outcome measurement, Hamilton Rating Scale for Depression (HAMD) was used most commonly. Meta-analysis of 10 studies revealed effective rate of Chinese Herbal Medicine groups (CHM) was significantly higher than Western Medicine groups (WM) (RR: 1.14, 95% CI: 1.02 to 1.27, p=0.02, $I^2=40%$). There was no significant difference in effective rate of CHM+WM and WM (RR: 1.12, 95% CI: 0.84 to 1.49, p=0.46, $I^2=83%$). And also, effective rate of Acupuncture group (Acu) revealed no significant difference compared to that of WM (RR: 1.17, 95% CI: 0.95 to 1.44, p=0.13, $I^2=84%$). For HAMD, there was significant difference in CHM vs, WM group and Acu vs. WM group. Quality of selected 12 RCTs was low. Conclusions: Therapies practiced in traditional Chinese medicine may be effective options for somatization disorder. treatment. For further clinical studies in Korean medicine, this study could be groundwork for development of diagnosis and treatment on somatization disorder.

The Effectiveness of Moxibustion Treatment for Primary Dysmenorrhea: A Systematic Review and Meta-Analysis (원발성 월경곤란증의 뜸 치료에 대한 체계적 문헌고찰 및 메타분석)

  • Lee, Hye-In;Baek, Seon-Eun;Lee, Ho-Jung;Park, Kyoung-Sun;Lee, Jin-Moo;Yoo, Jeong-Eun
    • The Journal of Korean Obstetrics and Gynecology
    • /
    • v.30 no.2
    • /
    • pp.107-119
    • /
    • 2017
  • Objectives: The purpose of this study is to investigate the effectiveness of moxibustion for primary dysmenorrhea (PD). Methods: We searched 10 electronic databases (CNKI, WANFANG, VIP, AMED, CiNii, Embase, PubMed, Cochrane, OASIS, Korea Traditional Knowledge Portal) to identify eligible studies published before November 2016. We included randomized controlled clinical trials (RCTs) using moxibustion for primary dysmenorrhea. The methodological quality of each RCT was assessed by the Cochrane risk of bias tool. Results: Ten RCT studies were eligible in our review. The overall risk of bias was evaluated as unclear. The meta-analysis of 4 trials indicated that favorable results for the use of moxibustion. Conclusions: This systematic review and meta-analysis of clinical trials suggests that moxibustion can achieve good efficacy for PD patients. However, because of studies included analysis was biased due to unclear risk of bias and unreliable study design, future high-quality RCT studies are needed to determine the association moxibustion with PD.

Association between the NQO1 C609T Polymorphism with Hepatocellular Carcinoma Risk in the Chinese Population

  • Zhao, Hong;Zou, Li-Wei;Zheng, Sui-Sheng;Geng, Xiao-Ping
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.5
    • /
    • pp.1821-1825
    • /
    • 2015
  • Background: Associations between the NQO1 C609T polymorphism and hepatocellular carcinoma (HCC) risk are a subject of debate. We therefore performed the present meta-analysis to evaluate links with HCC susceptibility. Materials and Methods: Several major databases (PubMed, EBSCO), the Chinese national knowledge infrastructure (CNKI) and the Wanfang database were searched for eligible studies. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to measure the strength of associations. Results: A total of 4 studies including 1,325 patients and 1,367 controls were identified. There was a significant association between NQO1 C609T polymorphism and HCC for all genetic models (allelic model: OR=1.45, 95%CI=1.23-1.72, p<0.01; additive model: OR=1.96, 95%CI=1.57-2.43, p<0.01; dominant model: OR=1.62, 95%CI=1.38-1.91, p<0.01; and recessive model: OR=1.53, 95%CI=1.26-1.84, p<0.01). On subgroup analysis, similarly results were identified in Asians. For Asians, the combined ORs and 95% CIs were (allelic model: OR=1.50, 95%CI=1.24-1.82, p<0.01; additive model: OR=2.11, 95%CI=1.48-3.01, p<0.01; dominant model: OR=1.69, 95%CI=1.42-2.02, p<0.01; and recessive model: OR=1.59, 95%CI=1.16-2.19, p<0.01). Conclusions: The current meta-analysis suggested that the NQO1 C609T polymorphism could be a risk factor for developing HCC, particularly in the Chinese population.

A Study on the Recognition of Dryness pathogen and Dryness disease - Focusing on the main argument in history - (조사(燥邪)와 조병(燥病)의 인식에 대한 고찰 - 역대 주요 논쟁을 중심으로 -)

  • Yun, Ki-ryoung;Jeong, Chang-hyun;Baik, You-sang;Jang, Woo-chang
    • Journal of Korean Medical classics
    • /
    • v.30 no.1
    • /
    • pp.111-133
    • /
    • 2017
  • Objectives : Dryness pathogen, which is one of six pathogenic factors, causes dryness diseases. Currently, the theory on dryness disease is composed of external dryness and internal dryness. External dryness, in turn, is composed of cool dryness and warm dryness. However, these categorizations and their symptoms bear ambiguity for many reasons. Therefore, this paper aims to review various texts in order to study the special features of dryness pathogen and dryness disease. Methods : Texts that deal with dryness pathogen and dryness disease were studied. Most texts are comprised of dissertations and historical medical texts, therefore, CNKI and The Sikuquanshu's databases, and Traditional Chinese Medical(TCM) book webdatabases were utilized. Materials are listed in chronological order, and their main points regarding dryness pathogen and dryness disease are compared. Results & Conclusions : It is difficult to accept the assertion that dryness pathogen does not lead to external dryness. Dryness does not have the elements of chill and fever in itself. Dryness's elements of chill and fever are determined in the ways they combine with each individual element. Moreover, the symptoms of chill and fever on dryness disease are subject to the host's body type. External dryness and internal dryness cannot be discussed within an identical premise. Whereas the dryness in external dryness signifies the cause of a disease, the dryness in internal dryness is the consequence of a disease. In other words, internal dryness revolves around cause of disease and external dryness revolves around the mechanic of disease. It's difficult to determine whether these diseases are caused by dryness or wetness in Autumn. There is an understanding which integrates these together through the Yunqi theory, but it is imperfect.

Trends in Treatment with and Mechanism of Moxibustion in Cancer Patients: A Review (암 환자에 대한 구법의 치료와 메커니즘에 대한 최신 국내외 연구 현황)

  • Yoon, Hae-chang;Kang, Ji-young;Kim, Jun-young;Joung, Jin-yong;Son, Chang-gue;Lee, Nam-heon;Cho, Jung-hyo
    • The Journal of Internal Korean Medicine
    • /
    • v.36 no.3
    • /
    • pp.361-379
    • /
    • 2015
  • Objectives This study aims to review and summarize existing evidence on moxibustion treatment for cancer patients. Methods Literature published until May 2015 in international journals were searched on PubMed, CAJ (CNKI-Medicine), NDSL (National discovery for science leaders), Sage Journal, ScienceDirect, Taylor&Francis Online (HSS), and Wiley Interscience (including Blackwell); and articles in Korean journals were searched on Korean Studies Information Service System (KISS), DBPIA, E-Article, KSI e-book, New article, Korea Institute of Science and Technology Information (KISTI), and Kyobo scholar. Results We analyzed 65 relevant studies. The number of studies conducted annually has increased and most are conducted in Korea and China. Moxibustion decreases the side effects of palliative treatment, thereby synergizing with anticancer treatment; it also improves the immune system, reduces tumor factors, and relieves symptoms. The mechanism of moxibustion is multi-fold: thermo, chemo, aero and kinetic. Only the kinetic effect is not significant. It also needs a complement to moxibustion because of harmful smoke. Conclusions Thus, the effect and mechanism of moxibustion in cancer patients was reviewed. There is an unmet need to develop a model of moxibustion and test it based on Korean medicine.

Review of Clinical Studies for Herbal Medicine Treatment on Childhood Obesity - Focusing on Studies from the China Academic Journal (CAJ) - (중의학 데이터베이스 (CAJ)를 이용한 소아 비만의 한약치료에 대한 임상 연구 동향)

  • Kim, Seo Hyeong;Ryu, Hyang;Kim, Kibong;Cheon, Jin Hong
    • The Journal of Pediatrics of Korean Medicine
    • /
    • v.32 no.3
    • /
    • pp.26-43
    • /
    • 2018
  • Objectives The purpose of this study was to analyze recent traditional Chinese medicine clinical studies for treatment of childhood obesity. Methods We analyzed 11 clinical studies from January, 2000 to March, 2018 about childhood obesity from the China Academic Journal (CAJ) and China National Knowledge Infrastructure (CNKI). All selected studies were Randomized Controlled Trials and analyzed in order of publication year, demographic information, treatment method, evaluation methods, results, adverse reactions and relapse after treatment discontinuation. Results The main Traditional Chinese Medicine (TCM) treatment was the herbal decoctions, granules and pills. In most studies, the total efficacy of the treatment group was reported to be higher than that of the control group. Adverse reactions were found in small number of studies. Frequently used medical herbs were Crataegi Fructus (山?), Atractylodis Rhizoma (蒼朮), Citri Pericarpium (陳皮), Poria (茯?), and Nelumbinis Folium (荷葉). Also, Water-draining and swelling-dispersing medicinal (利水退腫藥), Qi-regulating medicinal (理氣藥), Resolving dampness with aroma medicinal (芳香化濕藥), Blood-activating and stasis-dispelling medicinal (活血祛瘀藥), Qi-tonifying medicinal (補氣藥), and Digestant medicinal (消食藥) were commonly used. Conclusions This study showed that traditional Chinese medicine, especially herbal medicine treatment can be effective and safe option for treating childhood obesity. These research results can be utilized in other clinical studies as well as in treatment of childhood obesity. Additional well-designed randomized controlled trials and systematic reviews are need to confirm the conclusion.

A Literature Study on Acupuncture for Spastic Cerebral Palsy (강직성 뇌성마비의 침자치료에 대한 문헌고찰 - 최근 중의잡지를 중심으로 -)

  • Yu, Sun Ae;Cho, Sung Woo;Lee, Seung Yeon
    • The Journal of Pediatrics of Korean Medicine
    • /
    • v.29 no.4
    • /
    • pp.108-118
    • /
    • 2015
  • Objectives The purpose of this study is to look into the methods of acupuncture for spastic cerebral palsy. Methods 27 cases of the clinical literature were selected from 43 studies about cerebral palsy and spastics. Theses literature were published between the January 2010 to September 2015 by using the China Academic Journal (CAJ) of China National Knoweldge Infrastructure (CNKI). Results Most studies mentioned the effect of acupuncture (scalp, general) or acupoint-injection, derma needle, warm acupoint. It was more effective with other herbal complex rehabilitation therapy such as acupuncture, physical therapy occupational therapy, rehabilitation, and the complex speech therapy than just the herbal therapy alone. Acupuncture of acupoint-injection has overall 86~96% of rehabilitation rate. The acupuncture was often used with the general acupuncture and scalp acupuncture. Commonly used major acupuncture points were sishencong (四神總), bohui (百會), yundongqu (運動區), and pinghengqu (平衡區), Li11, Li04, Gb39, St41. The main acupoint-injection points were fengchi (Gb21) and jiexi (St41). For the injection, brain actiator, astragalus injection, cerebroprotein hydrolysate, Vit B1, Vit B2 were commonly used. Conclusion Acupuncture and acupoint-injection have been shown as an effective treatment on spastic cerebral palsy. The acupuncture was used often with the general acupuncture and scalp acupuncture all together.